Company intelligence / Profile preview

GeneThera

Westminster, Colorado, United Statesdnb.com ↗

Ownership: Private
Employees: ~5
Development stage: Other

Overview

GeneThera has developed commercial molecular diagnostic assays for zoonotic diseases such as Johne’s disease and BSE. The company has also developed a large-scale process for producing high-titer adenovirus/AAV vectors enabling the development of recombinant DNA vaccines against zoonotic pathogens. Its platform leverages robotics and AI to improve detection and management of infectious agents crossing from animals to humans. Clinical results are not detailed publicly but the company claims full product readiness for its diagnostic solutions.

Therapeutic areas: GastroenterologyNeurologyInfectious Diseases
Modalities: Gene therapyDNA vaccineRecombinant proteinCRISPR-based therapyMolecular diagnostics
Industry: Molecular Diagnostics

Partnerships

Cumming Corporation – partnership to build a global network of high-safety laboratory facilities focused on zoonotic diseases

Beyond the preview

Go deeper on GeneThera.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GeneThera.

Explore the full profile